Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
2006
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
2008 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
2012
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Targeting Molecular and Cellular Inhibitory Mechanisms for Improvement of Antitumor Memory Responses Reactivated by Tumor Cell Vaccine
2007
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
2013
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
DNA methylation arrays as surrogate measures of cell mixture distribution
2012 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
2013
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer
2012
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
2008
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
2010 StandoutNobel
Role of AID in Tumorigenesis
2007 StandoutNobel
Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
2012
Coordinated regulation of myeloid cells by tumours
2012 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer
2012
The Epigenomics of Cancer
2007 Standout
Preoperative Prognostic Score for Predicting Survival After Hepatic Resection for Colorectal Liver Metastases
2007
A systematic review of the association between circulating concentrations of C reactive protein and cancer
2007
C-reactive protein as a biomarker for urological cancers
2011
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
2011
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
2009
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma
2005
Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors
2011
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
2008
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival
2006
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer
2007
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
Microenvironmental regulation of metastasis
2008 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase‐2 expression in clear cell renal cell carcinoma
2008
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer
2008
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Neutrophils in cancer: neutral no more
2016 Standout
Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
2006
Cancer-related inflammation and treatment effectiveness
2014 Standout
Surgical technique and systemic inflammation influences long‐term disease‐free survival following hepatic resection for colorectal metastasis
2008
Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer
2011
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Frequency of regulatory T cells in peripheral blood and in tumour‐infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma
2010
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Significance of B7-H1 Overexpression in Kidney Cancer
2006
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
2012 Standout
Comparison of the Prognostic Value of Tumour‐ and Patient‐Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer
2011
B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival
2006
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
2009
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Preoperative Neutrophil‐to‐Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
2008
The Impact of Tonsillectomy upon the Risk of Oropharyngeal Carcinoma Diagnosis and Prognosis in the Danish Cancer Registry
2015
Inflammation, a Key Event in Cancer Development
2006
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
2015
Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer
2009
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
2006
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
2009
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma
2007
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
2009
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
2012
Works of Peter McArdle being referenced
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
2005
The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer
2004
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
2003
Systemic Inflammatory Response, Prostate-Specific Antigen and Survival in Patients with Metastatic Prostate Cancer
2006
Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer
2005
The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
2004
Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up
2010
The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer
2008